Literature DB >> 25976672

Mig-6 regulates endometrial genes involved in cell cycle and progesterone signaling.

Jung-Yoon Yoo1, Tae Hoon Kim1, Jae Hee Lee1, Sally L Dunwoodie2, Bon Jeong Ku3, Jae-Wook Jeong4.   

Abstract

Mitogen inducible gene 6 (Mig-6) is an important mediator of progesterone (P4) signaling to inhibit estrogen (E2) signaling in the uterus. Ablation of Mig-6 in the murine uterus leads to the development of endometrial hyperplasia and E2-induced endometrial cancer. To identify the molecular pathways regulated by Mig-6, we performed microarray analysis on the uterus of ovariectomized Mig-6(f/f) and PGR(cre/+)Mig-6(f/f) (Mig-6(d/d)) mice treated with vehicle or P4 for 6 h. The results revealed that 772 transcripts were significantly regulated in the Mig-6(d/d) uterus treated with vehicle as compared with Mig-6(f/f) mice. The pathway analysis showed that Mig-6 suppressed the expression of gene-related cell cycle regulation in the absence of ovarian steroid hormone. The epithelium of Mig-6(d/d) mice showed a significant increase in the number of proliferative cells compared to Mig-6(f/f) mice. This microarray analysis also revealed that 324 genes are regulated by P4 as well as Mig-6. Cited2, the developmentally important transcription factor, was identified as being regulated by the P4-Mig-6 axis. To determine the role of Cited2 in the uterus, we used the mice with Cited2 that were conditionally ablated in progesterone receptor-positive cells (PGR(cre/+)Cited2(f/f); Cited2(d/d)). Ablation of Cited2 in the uterus resulted in a significant reduction in the ability of the uterus to undergo a hormonally induced decidual reaction. Identification and analysis of these responsive genes will help define the role of P4 as well as Mig-6 in regulating uterine biology.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cited2; Mig-6; Progesterone; Uterus

Mesh:

Substances:

Year:  2015        PMID: 25976672      PMCID: PMC4461536          DOI: 10.1016/j.bbrc.2015.04.146

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness.

Authors:  Tina R Hubler; Wesley B Denny; Donna L Valentine; Joyce Cheung-Flynn; David F Smith; Jonathan G Scammell
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

Review 2.  Progestin regulation of cellular proliferation.

Authors:  C L Clarke; R L Sutherland
Journal:  Endocr Rev       Date:  1990-05       Impact factor: 19.871

3.  Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.

Authors:  C E Ehrlich; P C Young; F B Stehman; G P Sutton; W M Alford
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

Review 4.  Mechanisms of action of estrogen and progesterone.

Authors:  Francesco J DeMayo; Bihong Zhao; Norio Takamoto; Sophia Y Tsai
Journal:  Ann N Y Acad Sci       Date:  2002-03       Impact factor: 5.691

5.  Generation of a Mig-6 conditional null allele.

Authors:  Nili Jin; Jennifer L Gilbert; Russell R Broaddus; Francesco J Demayo; Jae-Wook Jeong
Journal:  Genesis       Date:  2007-11       Impact factor: 2.487

6.  Ablation of Indian hedgehog in the murine uterus results in decreased cell cycle progression, aberrant epidermal growth factor signaling, and increased estrogen signaling.

Authors:  Heather L Franco; Kevin Y Lee; Russell R Broaddus; Lisa D White; Beate Lanske; John P Lydon; Jae-Wook Jeong; Francesco J DeMayo
Journal:  Biol Reprod       Date:  2010-01-07       Impact factor: 4.285

Review 7.  Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms.

Authors:  Orla M Conneely; Biserka Mulac-Jericevic; John P Lydon
Journal:  Steroids       Date:  2003-11       Impact factor: 2.668

8.  Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.

Authors:  Tae Hoon Kim; Dong-Kee Lee; Sung-Nam Cho; Grant D Orvis; Richard R Behringer; John P Lydon; Bon Jeong Ku; Adrienne S McCampbell; Russell R Broaddus; Jae-Wook Jeong
Journal:  Cancer Res       Date:  2013-06-27       Impact factor: 12.701

9.  Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer.

Authors:  Koji Yamazawa; Makiko Hirai; Atsuya Fujito; Hirokata Nishi; Fumitoshi Terauchi; Hiroshi Ishikura; Makio Shozu; Keiichi Isaka
Journal:  Hum Reprod       Date:  2007-04-21       Impact factor: 6.918

10.  Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles.

Authors:  Ricardo F Savaris; Jeremy M Groll; Steven L Young; Franco J DeMayo; Jae-Wook Jeong; Amy E Hamilton; Linda C Giudice; Bruce A Lessey
Journal:  J Clin Endocrinol Metab       Date:  2011-03-16       Impact factor: 5.958

View more
  8 in total

1.  Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels.

Authors:  Lauren Osborne; Makena Clive; Mary Kimmel; Fiona Gispen; Jerry Guintivano; Tori Brown; Olivia Cox; Jennifer Judy; Samantha Meilman; Aviva Braier; Matthias W Beckmann; Johannes Kornhuber; Peter A Fasching; Fernando Goes; Jennifer L Payne; Elisabeth B Binder; Zachary Kaminsky
Journal:  Neuropsychopharmacology       Date:  2015-10-27       Impact factor: 7.853

2.  CITED2 modulation of trophoblast cell differentiation: insights from global transcriptome analysis.

Authors:  Kazuhiko Imakawa; Pramod Dhakal; Kaiyu Kubota; Kazuya Kusama; Damayanti Chakraborty; M A Karim Rumi; Michael J Soares
Journal:  Reproduction       Date:  2016-02-25       Impact factor: 3.906

3.  Progesterone Resistance in Endometriosis Is Modulated by the Altered Expression of MicroRNA-29c and FKBP4.

Authors:  Niraj R Joshi; Eduardo H Miyadahira; Yalda Afshar; Jae-Wook Jeong; Steven L Young; Bruce A Lessey; Paulo C Serafini; Asgerally T Fazleabas
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

4.  LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.

Authors:  Christopher G Peña; Yuji Nakada; Hatice D Saatcioglu; Gina M Aloisio; Ileana Cuevas; Song Zhang; David S Miller; Jayanthi S Lea; Kwok-Kin Wong; Ralph J DeBerardinis; Antonio L Amelio; Rolf A Brekken; Diego H Castrillon
Journal:  J Clin Invest       Date:  2015-09-28       Impact factor: 14.808

Review 5.  Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium.

Authors:  Zhu Xue; Juanli Li; Jiaxing Feng; Han Han; Jing Zhao; Jiao Zhang; Yanhua Han; Xiaoke Wu; Yuehui Zhang
Journal:  Front Physiol       Date:  2021-12-17       Impact factor: 4.566

6.  Loss of MIG-6 results in endometrial progesterone resistance via ERBB2.

Authors:  Jung-Yoon Yoo; Tae Hoon Kim; Jung-Ho Shin; Ryan M Marquardt; Ulrich Müller; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Ho-Geun Yoon; Jae-Wook Jeong
Journal:  Nat Commun       Date:  2022-03-01       Impact factor: 14.919

Review 7.  Progesterone Actions and Resistance in Gynecological Disorders.

Authors:  James A MacLean; Kanako Hayashi
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

Review 8.  Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?

Authors:  Ryan M Marquardt; Tae Hoon Kim; Jung-Ho Shin; Jae-Wook Jeong
Journal:  Int J Mol Sci       Date:  2019-08-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.